Gene Expression Analysis Market Worth $4.3 Billion by 2018 - 47 ABC - Delmarva's Choice

Gene Expression Analysis Market Worth $4.3 Billion by 2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE MarketsandMarkets

DALLAS, February 19, 2014 /PRNewswire/ --

According to the new market research report, "Gene Expression Analysis Market   - by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications - Global Forecast To 2018", published by MarketsandMarkets, Gene expression analysis market estimated at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, growing at a CAGR of 10.4% from 2013 to 2018.

Browse 72 market data tables and 20 figures spread through 227 pages and in-depth TOC on "Gene Expression Analysis Market - Global Forecast To 2018"

http://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html

Early buyers will receive 10% customization on this report.

The Gene Expression Analysis Market analyzes and studies the major market drivers and restraints in North America, Europe, Asia, and the Rest of the World (RoW).

This report covers the definition, description, and forecast of the global Gene Expression Analysis Market in terms of instrumentation, consumables, services, and applications. Based on technology, the Gene Expression Analysis Instrumentation Market comprises DNA microarrays, real-time PCR, next-generation sequencing, and others. The consumables market is categorized into DNA chips and reagents, while the services market is further sub-segmented into gene expression profiling services, bioinformatics solutions, data analysis software, and others.

Over the years, Gene Expression Analysis has evolved significantly and is widely used for the diagnosis and treatment of various disorders like cancer, Alzheimer's, and Parkinson's, among others. In the past few years, the market has witnessed significant technological advancements, as companies have introduced newer sequencing and analysis platforms. This has aided in the diagnosis and treatment of diseases. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the Gene Expression Analysis Market.

North America dominated the global Gene Expression Analysis Market, followed by Europe and Asia. The continued developments in the North American market are triggered by the increase in funding, to address the growth in the number of cancer patients. Asia is expected to grow at the highest CAGR. This can be attributed to the presence of high-growth markets such as India and China, improved funding scenario in this region, increasing number of conferences and exhibitions on gene expression, and increased focus on cancer research.

Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global Gene Expression Analysis Market.

Browse related reports

Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, healthcare information technology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Powered by WorldNow All content © Copyright 2000 - 2014 WorldNow and WMDT. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.